Preliminary Effectiveness and Feasibility of Transcutaneous Acupoints Electrical Stimulation on Chemotherapy-induced Peripheral Neuropathy Among Children With Acute Lymphoblastic Leukemia

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age10-17
SponsorThe Hong Kong Polytechnic University

About this trial

The first goal of this clinical trial is to assess the feasibility of transcutaneous acupoints electrical stimulation (TAES) on children with acute lymphoblastic leukemia (ALL). The second goal of this clinical trial is to evaluate the preliminary effectiveness of TAES on subject chemotherapy induced peripheral neuropathy (CIPN) symptoms severity, physical function, psychological distress, and quality of life at postintervention and at 1-, and 3-month follow-up postintervention.

The main questions it aims to answer are:

1. What is the feasibility of implementing TAES for children with ALL, as measured by the eligibility rate, consent rate, randomization rate etc.? 2. Does TAES can improve CIPN symptoms severity, physical function, psychological distress, quality of life in children with ALL compared with sham control group?

This proposed research is designed to conduct a two-arm RCT comparing TAES to sham TAES in children with ALL. Subjects in TAES group will receive 8 weeks TAES on four acupoints. Subjects in sham control group will follow the same protocol as the TEAS treatment but with 0 mA, 0 Hz TAES. These two groups will be provided with a leaflet containing self-help materials for CIPN.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

age between 10 and 17 years old

diagnosed with ALL

received neurotoxic chemotherapy

have developed score 9 or above CIPN symptoms according to Pediatric Chemotherapy-Induced Neuropathy (P-CIN)

Disqualifiers

receiving multiple cancer treatment

had a diagnosis of cancer in the central nervous system cancer, cancer relapse or secondary cancer

having other neuromuscular disorders, for example, traumatic brain injury and cerebral palsy

having other systematic diseases that cause toxicity in the peripheral nervous system, such as sickle cell disease (SCD), Guillain-Barre ́ Syndrome (GBS), anterior cutaneous nerve entrapment syndrome (ACNES), obstetric brachial plexus injury (OBPI), type I diabetes mellitus, postherpetic neuralgia (PHN), peroneal nerve injury, and reflex sympathetic dystrophy (RSD)

Trial design

Design model

Parallel

Treatments tested in this trial

  • Transcutaneous Acupoints Electrical Stimulation (TAES)

    Behavioral

    Transcutaneous Acupoints Electrical Stimulation (TAES) is a kind of physical therapy that use electric current through the electrodes placed on the surface of acupoints to produce clinical effects in the human body.

  • No intervention: sham TAES

    Other intervention

    It is designed to look, feel, and be administered identically to the active treatment but lacks its core therapeutic component.

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: Transcutaneous Acupoints Electrical Stimulation (TAES) groupExperimental treatment 1 intervention
Group B: Sham control groupSham comparator 1 intervention

Trial outcomes

Primary outcomes

1

Feasibility measure - Screening rate

The number of participants being screened divided by the number of participants available for screening

Time frame
Baseline
2

Feasibility measure - Eligibility rate

The number of eligible participants divided by the number of screened participants.

Time frame
Baseline
3

Feasibility measure - Recruitment rate

The number of eligible participants who consent to join divided by the number of eligible participants

Time frame
Baseline
4

Feasibility measure - Randomization rate

The number of consented participants being randomized divided by the number of consented participants

Time frame
Baseline

Secondary outcomes

1

CIPN severity - Pediatric Chemotherapy-Induced Neuropathy (P-CIN)

To evaluate the severity of CIPN. The Pediatric Chemotherapy-Induced Neuropathy scale contains 13 items, with eight items to rate CIPN symptoms in the hands and feet and five items to rate the difficulty of performing functional tasks. The total score ranges from 0 to 65 with higher scores indicating more severe CIPN.

Time frame
Baseline, immediately after intervention (T1), 1 month after intervention (T2), and 3 month after intervention (T3)
2

Physical functioning - Timed Up and Go test

Timed Up and Go test (TUG) will be used to evaluate the physical function in children with ALL.

Time frame
Baseline, immediately after intervention (T1), 1 month after intervention (T2), and 3 month after intervention (T3)
3

Physical functioning - 30-second sitting-rising test

30-second sitting-rising test will be used to evaluate the physical function in children with ALL.

Time frame
Baseline, immediately after intervention (T1), 1 month after intervention (T2), and 3 month after intervention (T3)
4

Physical functioning - grip strength

Handheld grip strength meter will be used to evaluate the physical function in children with ALL.

Time frame
Baseline, immediately after intervention (T1), 1 month after intervention (T2), and 3 month after intervention (T3)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

The Hong Kong Polytechnic University

Lead sponsor

Zhengzhou University

Collaborator

This trial is not recruiting at the moment. You can still explore other options: